$Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study$

Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2015-04, Vol.100 (4), p.e128-e131
Hauptverfasser:	Chevallier, Patrice, Huguet, Francoise, Raffoux, Emmanuel, Etienne, Anne, Leguay, Thibaut, Isnard, Francoise, Robillard, Nelly, Guillaume, Thierry, Delaunay, Jacques, Charbonnier, Aude, Pigneux, Arnaud, Peterlin, Pierre, Bené, Marie C, Wegener, William A, Goldenberg, David M, Dombret, Hervé
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Dexamethasone - administration & dosage Humans Online Only Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology Recurrence Sialic Acid Binding Ig-like Lectin 2 - metabolism Treatment Outcome Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!